Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1997 Aug;41(8):1673–1676. doi: 10.1128/aac.41.8.1673

Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis.

M S Rouse 1, J M Steckelberg 1, C M Brandt 1, R Patel 1, J M Miro 1, W R Wilson 1
PMCID: PMC163983  PMID: 9257739

Abstract

The efficacy of azithromycin or clarithromycin was compared to that of amoxicillin, clindamycin, or erythromycin for the prevention of viridans group streptococcus experimental endocarditis. Rabbits with catheter-induced aortic valve vegetations were given no antibiotics or two doses of amoxicillin at 25 mg/kg of body weight, azithromycin at 10 mg/kg, clarithromycin at 10 mg/kg, clindamycin at 40 mg/kg followed by clindamycin at 20 mg/kg, or erythromycin at 10 mg/kg. Antibiotics were administered 0.5 h before and 5.5 h after intravenous infusion of 5 x 10(5) CFU of Streptococcus milleri. Forty-eight hours after bacterial inoculation, the rabbits were killed and aortic valve vegetations were aseptically removed and cultured for bacteria. Infective endocarditis occurred in 88% of untreated animals, 1% of animals receiving amoxicillin, 9% of animals receiving erythromycin, 0% of animals receiving clindamycin, 2.5% of animals receiving clarithromycin, and 1% of animals receiving azithromycin. All five regimens were more effective (P < 0.001) than no prophylaxis. Erythromycin was less effective (P < 0.05) than amoxicillin or clindamycin. Azithromycin or clarithromycin was as effective as amoxicillin, clindamycin, or erythromycin for the prevention of viridans group streptococcus experimental endocarditis in this model.

Full Text

The Full Text of this article is available as a PDF (193.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson G., Esmonde T. S., Coles S., Macklin J., Carnegie C. A comparative safety and efficacy study of clarithromycin and erythromycin stearate in community-acquired pneumonia. J Antimicrob Chemother. 1991 Feb;27 (Suppl A):117–124. doi: 10.1093/jac/27.suppl_a.117. [DOI] [PubMed] [Google Scholar]
  2. Chu S. Y., Sennello L. T., Sonders R. C. Simultaneous determination of clarithromycin and 14(R)-hydroxyclarithromycin in plasma and urine using high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1991 Nov 15;571(1-2):199–208. doi: 10.1016/0378-4347(91)80446-j. [DOI] [PubMed] [Google Scholar]
  3. Dajani A. S., Bisno A. L., Chung K. J., Durack D. T., Freed M., Gerber M. A., Karchmer A. W., Millard H. D., Rahimtoola S., Shulman S. T. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1990 Dec 12;264(22):2919–2922. [PubMed] [Google Scholar]
  4. Dajani A. S., Taubert K. A., Wilson W., Bolger A. F., Bayer A., Ferrieri P., Gewitz M. H., Shulman S. T., Nouri S., Newburger J. W. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA. 1997 Jun 11;277(22):1794–1801. [PubMed] [Google Scholar]
  5. Durack D. T., Beeson P. B., Petersdorf R. G. Experimental bacterial endocarditis. 3. Production and progress of the disease in rabbits. Br J Exp Pathol. 1973 Apr;54(2):142–151. [PMC free article] [PubMed] [Google Scholar]
  6. Durack D. T., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest. 1973 Mar;52(3):592–598. doi: 10.1172/JCI107220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fluckiger U., Francioli P., Blaser J., Glauser M. P., Moreillon P. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J Infect Dis. 1994 Jun;169(6):1397–1400. doi: 10.1093/infdis/169.6.1397. [DOI] [PubMed] [Google Scholar]
  8. Garrison P. K., Freedman L. R. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med. 1970 Jun;42(6):394–410. [PMC free article] [PubMed] [Google Scholar]
  9. Glauser M. P., Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis. 1982 Dec;146(6):806–810. doi: 10.1093/infdis/146.6.806. [DOI] [PubMed] [Google Scholar]
  10. Hall G., Hedström S. A., Heimdahl A., Nord C. E. Prophylactic administration of penicillins for endocarditis does not reduce the incidence of postextraction bacteremia. Clin Infect Dis. 1993 Aug;17(2):188–194. doi: 10.1093/clinids/17.2.188. [DOI] [PubMed] [Google Scholar]
  11. Horstkotte D., Friedrichs W., Pippert H., Bircks W., Loogen F. Nutzen der Endokarditisprophylaxe bei Patienten mit prothetischen Herzklappen. Z Kardiol. 1986 Jan;75(1):8–11. [PubMed] [Google Scholar]
  12. Imperiale T. F., Horwitz R. I. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med. 1990 Feb;88(2):131–136. doi: 10.1016/0002-9343(90)90461-l. [DOI] [PubMed] [Google Scholar]
  13. Malinverni R., Overholser C. D., Bille J., Glauser M. P. Antibiotic prophylaxis of experimental endocarditis after dental extractions. Circulation. 1988 Jan;77(1):182–187. doi: 10.1161/01.cir.77.1.182. [DOI] [PubMed] [Google Scholar]
  14. McWhinney P. H., Patel S., Whiley R. A., Hardie J. M., Gillespie S. H., Kibbler C. C. Activities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacin. Antimicrob Agents Chemother. 1993 Nov;37(11):2493–2495. doi: 10.1128/aac.37.11.2493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pelletier L. L., Jr, Durack D. T., Petersdorf R. G. Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis. J Clin Invest. 1975 Aug;56(2):319–330. doi: 10.1172/JCI108096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vermot D., Entenza J. M., Vouillamoz J., Glauser M. P., Moreillon P. Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrob Agents Chemother. 1996 Mar;40(3):809–811. doi: 10.1128/aac.40.3.809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wahl M. J. Myths of dental-induced endocarditis. Arch Intern Med. 1994 Jan 24;154(2):137–144. [PubMed] [Google Scholar]
  18. Williams J. D., Maskell J. P., Shain H., Chrysos G., Sefton A. M., Fraser H. Y., Hardie J. M. Comparative in-vitro activity of azithromycin, macrolides (erythromycin, clarithromycin and spiramycin) and streptogramin RP 59500 against oral organisms. J Antimicrob Chemother. 1992 Jul;30(1):27–37. doi: 10.1093/jac/30.1.27. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES